Skip to main content
SP5007,785.76-0.17%DOW53,732.41-0.20%NASDAQ26,729.16-0.28%BTC$62,945.00-0.85%ETH$1,880.32-0.35%GOLD$4,432.00+0.26%OIL$82.40+1.42%
Smart Investors Daily
Sign InSign Up Free
SR

NASDAQ · SRTS

Sensus Healthcare, Inc.

Healthcare · Medical - Devices

$2.86

Down-$0.30 (-9.49%)

Updated Aug 15, 2026, 4:15 AM

SID Score

4.5/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
63.07M
P/E ratio
-20.86
Dividend yield
0.00%
52-week range
$2.66 – $4.55
Volume
76.41K
Avg. volume
108.12K

Price performance

SRTS price history

1M range · 21 trading sessions · Daily adjusted prices

SRTS closed at $2.86 after 21 trading sessions, down 5.30% for the selected period.

Last close
$2.86
Period change
-5.30%
Period low
$2.85
Period high
$3.16
Daily close
View OHLC price history
SRTS OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Aug 14, 2026$2.80$2.98$2.80$2.8676.41K
Aug 13, 2026$3.19$3.34$3.02$3.1664.62K
Aug 12, 2026$3.095$3.18$3.095$3.138.05K
Aug 11, 2026$3.11$3.1999$3.048$3.1012.23K
Aug 10, 2026$3.09$3.1403$3.0401$3.0910.62K
Aug 7, 2026$2.97$3.07$2.96$3.0710.75K
Aug 6, 2026$2.95$2.98$2.92$2.9811K
Aug 5, 2026$2.98$2.98$2.92$2.946.6K
Aug 4, 2026$2.955$2.9996$2.955$2.9719.82K
Aug 3, 2026$2.92$2.98$2.91$2.9218.89K
Jul 31, 2026$2.93$2.9801$2.81$2.916.6K
Jul 30, 2026$2.85$2.9638$2.85$2.8913.76K
Jul 29, 2026$2.97$2.98$2.81$2.8540.14K
Jul 28, 2026$3.035$3.04$2.93$2.947.82K
Jul 27, 2026$3.03$3.06$3.00$3.0230.64K
Jul 24, 2026$2.99$3.10$2.9386$3.0319K
Jul 23, 2026$3.00$3.04$2.94$2.9419.92K
Jul 22, 2026$3.04$3.06$2.95$3.0431.67K
Jul 21, 2026$3.10$3.12$3.04$3.0413.75K
Jul 20, 2026$2.98$3.195$2.98$3.1025.65K
Jul 17, 2026$3.01$3.04$2.97$3.0218.58K

Latest SRTS news

The latest Smart Investors Daily articles mentioning SRTS.

Stock researchCompany · Overview

SRTS research

Overview

Company profile and research snapshot.

Company profile

Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$10.00
Implied upside
—
Analysts
9
SRTS recent ratings
DateFirmRatingTarget
Aug 14, 2026Lake StreetBuy—
Feb 17, 2026Maxim GroupBuy—
Aug 12, 2025HC Wainwright & Co.Buy—
Aug 8, 2025Lake StreetBuy—
May 19, 2025Maxim GroupBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Feb 26, 2026

Sensus Healthcare Introduces Sensus Link, Brings Advanced Operating Capabilities to the SRT-100™ Installed Base

BOCA RATON, Fla., February 26, 2026--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, introduces Sensus Link, a cloud-based software and connectivity solution intended to expand advanced operating capabilities across the Company’s SRT-100™ system installed base.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By